A Prescription Drug User Fee Act target date of February 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
A special diet is the main treatment for phenylketonuria. Medications are also available. Treatment and monitoring is lifelong. Phenylketonuria (PKU) is an inherited condition where the amino acid ...
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU 13-Jul-2022 / 07:00 CET/CEST Release of an ad hoc announcement ...
PORTLAND, Ore. — After 10 years of clinical trials, the Food and Drug Administration in May approved a new drug to treat the genetic disorder, phenylketonuria, (feanal-keto-nuria) or PKU. A Vancouver ...
The approval was based on data from a phase 3 open-label extension study that evaluated the long-term efficacy and safety of Palynziq in 86 adults with PKU. The Food and Drug Administration (FDA) has ...
SAN RAFAEL, Calif., Sept. 24, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that it has dosed the first participant in the global PHEARLESS Phase 1/2 study with BMN ...
- Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older - "We are excited to have reached this important milestone for those affected by PKU," said Matthew B. Klein ...
Synlogic SYBX announced that it has initiated the phase I study of SYNB1934, an investigational synthetic biotic candidate for the treatment of phenylketonuria (“PKU”). The candidate will be ...
NEW YORK (Reuters Health) - For women with the rare genetic disorder phenylketonuria, a new study highlights the importance of sticking with therapy before and during pregnancy. People with ...
Phenylketonuria (PKU) is the rare genetic condition caused due to increased phenylalanine levels in the blood. Excess phenylalanine amounts can lead to intellectual disability as well as other severe ...
The company is developing a novel enzyme-based treatment for phenylketonuria (PKU), but it faces growing competition from potentially curative gene therapies. Genetic medicines and cellular therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback